The effect of liraglutide on pancreatic hormones and its size.
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2019
Price : $35 *
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Parkinson's disease; Smoking withdrawal; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LIRAP
- 19 Jul 2019 This trial has been completed in Denmark, according to European Clinical Trials Database.
- 14 May 2019 Status changed from recruiting to active, no longer recruiting.
- 16 Apr 2019 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.